Skip Navigation

Breast Imaging Study
National Cancer Institute U.S. National Institutes of Healthwww.cancer.gov
 National Cancer Institute logo  Breast Imaging Study Contact Us
Home
home | background | purpose | eligibility/participation | expectations | team | publications | CGB | glossary | links | privacy

Study-Related Publications

  1. Koehly LM, Peters JA, Kenen R, Hoskins L, Ersig AL, Kuhn N, Loud J, Greene MH. Characteristics of health information gatherers, disseminators, and blockers within families at risk of hereditary cancer: Implications for family health communication interventions. Am J Public Health, in press.
  2. Loud JT, Beckjord E, Peters J, Nichols K, Giusti R, Greene MH. Tolerability of breast duct lavage in women from families at high genetic risk of breast cancer. BMC Women's Health, in press.
  3. Rebbeck TR, Antoniou AC, Llopis TC, Nevanlinna H, Aittomäki K, Simard J, Spurdle AB; KConFab, Couch FJ, Pereira LH, Greene MH, Andrulis IL; Ontario Cancer Genetics Network, Pasche B, Kaklamani V; Breast Cancer Family Registry, Hamann U, Szabo C, Peock S, Cook M, Harrington PA, Donaldson A, Male AM, Gardiner CA, Gregory H, Side LE, Robinson AC, Emmerson L, Ellis I; EMBRACE, Peyrat JP, Fournier J, Vennin P, Adenis C, Muller D, Fricker JP, Longy M, Sinilnikova OM, Stoppa-Lyonnet D; GEMO, Schmutzler RK, Versmold B, Engel C, Meindl A, Kast K, Schaefer D, Froster UG, Chenevix-Trench G, Easton DF. No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study. Breast Cancer Res Treat 2009 May;115(1):185-92.
  4. Loud JT, Thiébaut AC, Abati AD, Filie AC, Nichols K, Danforth D, Giusti R, Prindiville SA, Greene MH. Ductal lavage in women from BRCA1/2 families: is there a future for ductal lavage in women at increased genetic risk of breast cancer? Cancer Epidemiol Biomarkers Prev 2009 Apr;18(4):1243-51.
  5. Hoskins LM, Roy K, Peters JA, Loud JT, Greene MH. Disclosure of Positive BRCA1/2-Mutation Status in Young Couples: The Journey from Uncertainty to Bonding through Partner Support. Families Systems and Health 2008; 26:296-316.
  6. Mueller C, Mai P, Bucher J, Peters JA, Loud JT, Greene MH. Patterns of complementary and alternative medication use in women at increased genetic risk of breast and ovarian cancer. BMC Compl Alt Med 2008; 8:17.
  7. Koehly LM, Peters JA, Kuhn N, Hoskins L, Letocha A, Kenen R, Loud J, Greene MH. Sisters in hereditary breast and ovarian cancer families: communal coping, social integration, and psychological well-being. Psychooncology 2008 Aug;17(8):812-21.
  8. Bakos AD, Hutson SP, Loud JT, Peters JA, Giusti RM, Greene MH. BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience. Health Expect 2008 Sep;11(3):220-31.
  9. Abati A, Greene MH, Filie A, Loud J, Prindiville S, Danforth D, Giusti RM. Quantification of the cellular components of breast duct lavage samples. Diagn Cytopathol 2006; 34(1):78-81.
  10. Peters J, Hoskins L, Prindiville S, Kenen R, Greene MH. Evolution of the Colored Eco-Genetic Relationship Map (CEGRM) for assessing social functioning in women from hereditary breast/ovarian cancer families. J Genet Counsel 2006; 15(6):477-489.
  11. Peters JA, Kenen R, Giusti R, Loud J, Weissman N, Greene MH. Exploratory study of the feasibility and utility of the colored eco-genetic relationship map (CEGRM) in women at high genetic risk of developing breast cancer. Am J Med Genet A 2004; 130A(3):258-264.
 home | background | purpose | eligibility/participation | expectations | team | publications | CGB | glossary | links | privacy
National Cancer Institute Department of Health and Human Services National Institutes of Health USA.gov: The US government's official web portal